Search results for "Thrombosi"

showing 10 items of 634 documents

Coagulation abnormalities in lacunar and cortical ischemic stroke are quite different

1998

In order to clarify the coagulation profile accompanying ischemic stroke, which may have implications on therapeutic strategies, we performed a prospective study to evaluate the hemostatic parameters in the first 24 h after the onset of cortical atherothrombotic infarct and lacunar infarction. Twenty-seven patients with cortical atherothrombotic infarction and 27 patients with lacunar infarction, diagnosed on clinical and CT-scan criteria, had blood samples taken within the first 24 h after onset of the stroke, and before anticoagulant treatment had been started. Levels of fibrinogen, von Willebrand factor, D-dimers, prothrombin factors 1 + 2, anti-thrombin III, and C-protein and S-proteins…

Malemedicine.medical_specialtyFibrinogenBrain IschemiaVon Willebrand factorInternal medicinemedicineHumansProspective Studiescardiovascular diseasesProspective cohort studyStrokeAgedBlood coagulation testAged 80 and overHemostasisLupus anticoagulantbiologybusiness.industryThrombosisCerebral InfarctionGeneral MedicineMiddle Agedmedicine.diseaseCerebrovascular DisordersDementia Multi-InfarctNeurologyCoagulationHemostasisbiology.proteinCardiologyFemaleBlood Coagulation TestsNeurology (clinical)businessmedicine.drugNeurological Research
researchProduct

A prospective cohort study to identify and evaluate endotypes of venous thromboembolism: Rationale and design of the Genotyping and Molecular Phenoty…

2019

Abstract Several clinical, genetic and acquired risk factors for venous thromboembolism (VTE) have been identified. However, the molecular pathophysiology and mechanisms of disease progression remain poorly understood. This is reflected by uncertainties regarding the primary and secondary prevention of VTE and the optimal duration of antithrombotic therapy. A growing body of literature points to clinically relevant differences between VTE phenotypes (e.g. deep vein thrombosis (DVT) versus pulmonary embolism (PE), unprovoked versus provoked VTE). Extensive links to cardiovascular, inflammatory and immune-related morbidities are testament to the complexity of the disease. The GMP-VTE project …

Malemedicine.medical_specialtyGenotypeDeep veinDisease030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineAntithromboticmedicineHumansProspective Studiescardiovascular diseasesProspective cohort studybusiness.industryVenous ThromboembolismHematologyMiddle Agedequipment and suppliesmedicine.diseaseThrombosisPulmonary embolismPhenotypemedicine.anatomical_structure030220 oncology & carcinogenesisConcomitantFemalebusinessCohort studyThrombosis Research
researchProduct

Fatal venous air embolism: proof and volumetry by helical CT

1995

Malemedicine.medical_specialtyHeart Diseasesbusiness.industryMediastinumGeneral MedicineCranial SinusesIntracranial Embolism and ThrombosisMiddle AgedVenous air embolismHelical ctVeinsRadiographic Image EnhancementSuicideFatal OutcomeEmbolism AirHumansMedicineWounds GunshotRadiology Nuclear Medicine and imagingRadiologyPulmonary EmbolismTomography X-Ray ComputedbusinessNeckEuropean Journal of Radiology
researchProduct

More than one in two venous thromboembolism treated in French hospitals occurs during the hospital stays

2016

Objective The objective was to describe the prevalence of venous thromboembolism, pulmonary embolism, and deep vein thrombosis among hospitalized patients and the percentages of those occurring during the hospital stays. Methods French DRG gave now the opportunity to investigate the frequency of venous thromboembolism occurring during the hospital stay. Statistics are issued from the national PMSI MCO databases encoded using the CIM10. Since 2010–2011 it is possible to differentiate the reason for hospital admission from the pathologies which secondly occurred. Any stay with the ICD-10 codes selected was considered as a hospital-occurred thrombosis unless it was the principal diagnosis of t…

Malemedicine.medical_specialtyHospitalized patientsEpidemiologyDeep vein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEpidemiologymedicineHumans030212 general & internal medicineIntensive care medicineCancerbusiness.industryHospital-Acquired Pulmonary EmbolismGeneral MedicineVenous ThromboembolismLength of Stay[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseaseThrombosisPulmonary embolismmedicine.anatomical_structureEmergency medicinePulmonary-EmbolismFemaleFranceCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismVenous thromboembolism
researchProduct

Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke.

2009

Blood levels of total homocysteine (tHcy), cysteine (Cys), total and reduced glutathione (tGSH and rGSH), folic acid (FA), and vitamin B(12) (B(12) change during ischemic stroke as accompaniment of the tissue damage. The relationship between these changes remains scantly investigated. We evaluated the variation of these molecules in the 48 h after acute large artery atherothrombotic stroke (LAAS) and searched for the presence of matched variation of them. The study involved 50 subjects affected by acute LAAS and 49 healthy controls. Plasma levels of tHcy and Cys were significantly higher and serum levels of FA and B(12) and plasma levels of rGSH were significantly lower in the patients than…

Malemedicine.medical_specialtyLarge artery atherothrombotic strokeHomocysteineAtherothrombotic strokeHyperhomocysteinemiaDermatologyBrain Ischemiachemistry.chemical_compoundFolic AcidRisk FactorsSettore BIO/10 - BiochimicaInternal medicinemedicineHumansVitamin B12CysteineVitamin B(12)HomocysteineAgedAged 80 and overbusiness.industryLarge arteryGeneral MedicineGlutathionePlasma levelsVitaminsMiddle AgedGlutathioneReduced glutathioneStrokePsychiatry and Mental healthVitamin B 12EndocrinologychemistryFolic acidBiochemistryAcute DiseaseSettore MED/26 - NeurologiaFemaleNeurology (clinical)Intracranial ThrombosisbusinessCysteineNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Cardiovascular risk factor in MPN patients

2020

Malemedicine.medical_specialtyMyeloproliferative DisordersHematologybusiness.industryThrombosisHematologyMiddle AgedCardiovascular riskSettore MED/15 - Malattie Del SangueText miningCardiovascular DiseasesHeart Disease Risk FactorsInternal medicineHumansMedicineFemaleRisk factorCardiology and Cardiovascular MedicinebusinessAgedJournal of Thrombosis and Thrombolysis
researchProduct

Simultaneous appearance of leukemoid reaction and phlegmasia cerulea dolens

2012

A leukemoid reaction is an extreme form of reactive leukocytosis defined as granulocytic leukocytosis above 50 × 109/L produced by normal bone marrow, mostly in response to systemic infection or cancer. The mechanism as to how the haematopoetic system is altered to elevate production of myeloid cells is not known. A 69-year-old man presented with phlegmasia cerulea dolens caused by massive iliofemoral thrombosis. His workout at admission revealed absolute white blood cell count of 73.4 × 109/L, with neutrophil granulocyte of 68.5 × 109/L. The new increase in white blood cell count happened at day 5 after admission, when the haematoma of the anteromedial thigh was evacuated in general anaes…

Malemedicine.medical_specialtyNeutrophil granulocyte610 Medicine & healthGastroenterologySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineLeukocyte CountInternal medicineWhite blood cellmedicineHumansGeneral anaesthesiaLeukocytosisAgedPhlegmasia cerulea dolensphlegmasia cerulea dolenHematomabusiness.industryRemission InductionThrombosisGeneral MedicineThrombophlebitismedicine.diseaseThrombosisSystemic Inflammatory Response Syndromeleukemoid reaction10020 Clinic for Cardiac SurgerySurgerySystemic inflammatory response syndromemedicine.anatomical_structurephlegmasia cerulea dolens; leukemoid reactionmedicine.symptomCardiology and Cardiovascular MedicinebusinessLeukemoid reaction
researchProduct

Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality.

2019

Tissue factor is highly expressed in sub-endothelial tissue. The extracellular allosteric disulfide bond Cys186-Cys209 of human tissue factor shows high evolutionary conservation and in vitro evidence suggests that it significantly contributes to tissue factor procoagulant activity. To investigate the role of this allosteric disulfide bond in vivo, we generated a C213G mutant tissue factor mouse by replacing Cys213 of the corresponding disulfide Cys190-Cys213 in murine tissue factor. A bleeding phenotype was prominent in homozygous C213G tissue factor mice. Pre-natal lethality of 1/3rd of homozygous offspring was observed between E9.5 and E14.5 associated with placental hemorrhages. After b…

Malemedicine.medical_specialtyOffspring610 Medicine & healthHemorrhage030204 cardiovascular system & hematologyBiologymedicine.disease_causeArticleThromboplastin11459 Center for Molecular Cardiology03 medical and health sciencesTissue factorArterial Thrombosis; Blood Coagulation and Fibrinolysis; Disorders of Coagulation and FibrinolysisMice0302 clinical medicineIn vivoPregnancyInternal medicinemedicineExtracellularAnimalsDisulfidesMutationHematologyPhenotypeIn vitroEndocrinologyPhenotype10036 Medical Clinic10076 Center for Integrative Human PhysiologyHemostasisMutation10209 Clinic for CardiologyFemale030215 immunologyHaematologica
researchProduct

Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

2001

Background —Vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1, and E-selectin mediate adhesion and transmigration of leukocytes to the vascular endothelial wall and may promote plaque growth and instability. In a prospective study, we evaluated the effect of soluble adhesion molecules on the risk of future cardiovascular events among patients with angiographically documented coronary artery disease (CAD). Methods and Results —We obtained baseline samples from a prospective cohort of 1246 patients with CAD. Besides various markers of inflammation, soluble VCAM-1 (sVCAM-1), sICAM-1, and sE-selectin were determined. Follow-up information on cardiovascular even…

Malemedicine.medical_specialtyPathologyIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1Coronary DiseaseInflammationSensitivity and SpecificityGastroenterologyCohort StudiesCoronary artery diseasePredictive Value of TestsRisk FactorsGermanyPhysiology (medical)Internal medicineE-selectinmedicineHumansProspective StudiesProspective cohort studyAgedProportional Hazards ModelsbiologyCell adhesion moleculebusiness.industryMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseIntercellular adhesion moleculeThrombosisSurvival RateC-Reactive Proteinbiology.proteinFemalemedicine.symptomE-SelectinCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesFollow-Up StudiesCirculation
researchProduct

Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms

2009

The evidence that leukocytes may contribute to the pathogenesis of thrombosis in Chronic Myeloproliferative Neoplasms is increasing but not definitive. To further enforces whether an increased leukocyte count is associated with thrombosis and whether this effect can be modulated by cytoreductive therapy, we analyzed the clinical course of 187 patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) followed at two Italian Institutions over a period of 7 years. The association was measured at diagnosis or before thrombotic events: a multivariable analysis was carried out using data at baseline and time-dependent covariates. We found that white blood cells (WBC) count above 9.5…

Malemedicine.medical_specialtyPathologyLeukocytosismyeloproliferative neoplasm thrombosis jak2GastroenterologyLeukemia Myeloid Chronic Atypical BCR-ABL NegativeSettore MED/15 - Malattie Del SangueLeukocyte CountPolycythemia verahemic and lymphatic diseasesInternal medicinemedicineHumansHydroxyureaLeukocytosisRisk factorProspective cohort studyPolycythemia VeraMyeloproliferative neoplasmAgedbusiness.industryEssential thrombocythemiaHazard ratioThrombosisHematologyGeneral MedicineJanus Kinase 2Middle Agedmedicine.diseaseThrombosisMultivariate AnalysisFemalemedicine.symptombusinessThrombocythemia Essential
researchProduct